Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service

Scientific Journal Selector



Frontiers in Oncology


👁  484308 Views

 3565 Reviews  

 Open Access      SCIE      Official Website     Submission Website
Return to Search
 

*Average Peer Review
14 Weeks
*Competitiveness
CiteScore
6.2

CiteScore Rank
Subject Area Rank Percentile
Category: Medicine
Subcategory: Oncology
120 / 404
70%
Category: Medicine
Subcategory: Cancer Research
100 / 230
56%



Country/Area of Publication
Switzerland
Publication Frequency
Publisher
Frontiers Media S.A.

ISSN
2234-943X
E-ISSN
Year Publication Started
0

Self-citation (2023-2024)
5.70%
Annual Article Volume
4475
Gold OA Percentage
99.56%


Open Access Info
APC APC Waiver Other Charges
Yes: Check details
( USD3295; )
Yes: Check detailsNo

Journal Aim & Scope
Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.


Web of Science Quartiles
WOS Quartile: Q2

Quartiles By JIFCollectionQuartileRankPercentage
Category: ONCOLOGYSCIEQ2107/322
66.9%
Quartiles By JCICollectionQuartileRankPercentage
Category: ONCOLOGYSCIEQ2130/322
59.78%
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    Cancer Communications025.50
    CELLULAR ONCOLOGY010.30
    Translational Oncology418.40
    Journal of Gastric Cancer224.30
    Molecular and Cellular Oncology03.20
    Clinical and Experimental Morphology00.60
    Critical Reviews in Oncogenesis01.70
    International Journal of Medical Biochemistry00.50
    Advances in Cancer Biology Metastasis02.40
  • Frontiers in Oncology Frontiers in Oncology
    Predict CiteScore Trend:
    Steady Increase No Change Gradual Decline  Refresh
 
    👁  484308 Views
      3565 Reviews        
 
 
 

Select your rating and start your review of Frontiers in Oncology

 

    mulberry27
    Status: Rejected

    2025-02-24

    The research topic submitted did not reach the hands of the editor, and it was rejected on Monday after being submitted on Friday. The reason for this decision is very disappointing: Issues related to compliance with research integrity policies, journal guidelines, or any other essential editorial criteria were identified in this manuscript that prevent further review or publication. This manuscript does not meet the standards established for the journal to be considered for publication, and it is in accordance with Frontiers policies. I am not sure where the problem lies, but at least the rejection was quick. Previously, I submitted to the second-tier journal BMC Cancer and it was sent for review. I do not know what this third-tier journal is thinking.




    许鸽
    Status: Accepted

    2025-02-13

    Meta-analysis focusing on tumors:
    Submitted on October 18, 2024;
    Received review comments on December 22, 2024, with a total of 4 reviewers, 3 accepted with minor revisions, and 1 rejected;
    The editor returned with modifications twice, and accepted on January 28, 2025;
    Proofreading on February 7, 2025;
    Published online on February 12, 2025.
    The process from submission to acceptance took a total of over 3 months.




    hao先生
    Status: N/A

    2024-12-01

    How long did he review it in the end? He won't be looking for a new reviewer, will he?




    123
    Status: N/A

    2024-10-29

    One reviewer agreed to publish, while another rejected. Finally, in the editor module, the reasons for rejection were understood and modifications were made. It has been showing "review is ongoing" for two weeks without any changes. Does this mean rejection?




    墟散云泽
    Status: N/A

    2024-10-29

    I hope he endorses too.




    西域鹏云
    Status: N/A

    2024-10-28

    Trashy magazines, submitted two articles, one has been waiting for almost four months without being assigned an editor, no response to emails, the other is even worse, after submitting for half a year, the comments from reviewers gradually came back, with one rejecting and two agreeing to publish after major revisions. I thought it would go smoothly, but after waiting for over a month for the associate editor to make a decision, I received a replacement for no reason. The new associate editor took over and another month passed, only to be ultimately rejected, with the reason being that the reviewers' comments were superficial and the article had no value. I am truly frustrated, he made hundreds of patients' cases seem worthless. I will never submit again, and the magazine that is dragging its feet on assigning editors is also withdrawing submissions.




    Adelaide Lawson
    Status: N/A

    2024-10-24

    It has been a month since the editorial assignment was given, but editors have not been assigned yet. Despite reminders through emails, there has been no progress, which is causing concern. They are taking too long to take action.




    Adelaide Lawson
    Status: N/A

    2024-10-23

    Please be patient. It seems that everything is moving slowly. Mine has also been two months.




    仙灵佳惠
    Status: N/A

    2024-10-22

    I also submitted my article in June, and I have only received one review so far. Is it really this slow?




    Adelaide Lawson
    Status: N/A

    2024-10-12

    Submission success rate: 50.0
    Experience sharing: In August, I submitted my work and received feedback from a total of 2 reviewers, both of whom provided some suggestions. However, it is worth noting that they did not recommend rejection. The system does not show whether the work has been finalized or rejected. Currently, it is undergoing the third round of review by another reviewer.




Journals In The Same Field
CA-A CANCER JOURNAL FOR CLINICIANS
CiteScore: 873.20

LANCET
CiteScore: 148.10

NEW ENGLAND JOURNAL OF MEDICINE
CiteScore: 145.40

NATURE REVIEWS DRUG DISCOVERY
CiteScore: 137.40

NATURE REVIEWS CANCER
CiteScore: 111.90

NATURE MEDICINE
CiteScore: 100.90

Nature Reviews Clinical Oncology
CiteScore: 99.40

NATURE REVIEWS IMMUNOLOGY
CiteScore: 93.40

Lancet Respiratory Medicine
CiteScore: 87.10

Nature Reviews Disease Primers
CiteScore: 76.70



© 2010-2025  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
PrivacyTerms of Servic